Article info

Download PDFPDF
Genetically designing a more potent antipancreatic cancer agent by simultaneously co-targeting human IL13 and EGF receptors in a mouse xenograft model

Authors

  1. Dr D A Vallera, University of Minnesota Cancer Center, MMC: 367, Minneapolis, MN 55455, USA; valle001{at}umn.edu
View Full Text

Citation

Vallera DA, Stish BJ, Shu Y, et al
Genetically designing a more potent antipancreatic cancer agent by simultaneously co-targeting human IL13 and EGF receptors in a mouse xenograft model

Publication history

  • Revised November 30, 2007
  • Accepted December 1, 2007
  • First published January 25, 2008.
Online issue publication 
August 24, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.